Artículo
Cancer immune exclusion: breaking the barricade for a successful immunotherapy
Bruni, Sofia
; Mercogliano, María Florencia
; Mauro, Florencia Luciana; Cordo Russo, Rosalia Ines
; Schillaci, Roxana
Fecha de publicación:
03/2023
Editorial:
Frontiers Media
Revista:
Frontiers in Oncology
e-ISSN:
2234-943X
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
Immunotherapy has changed the course of cancer treatment. The initial steps were made through tumor-specific antibodies that guided the setup of an antitumor immune response. A new and successful generation of antibodies are designed to target immune checkpoint molecules aimed to reinvigorate the antitumor immune response. The cellular counterpart is the adoptive cell therapy, where specific immune cells are expanded or engineered to target cancer cells. In all cases, the key for achieving positive clinical resolutions rests upon the access of immune cells to the tumor. In this review, we focus on how the tumor microenvironment architecture, including stromal cells, immunosuppressive cells and extracellular matrix, protects tumor cells from an immune attack leading to immunotherapy resistance, and on the available strategies to tackle immune evasion.
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(IBYME)
Articulos de INST.DE BIOLOGIA Y MEDICINA EXPERIMENTAL (I)
Articulos de INST.DE BIOLOGIA Y MEDICINA EXPERIMENTAL (I)
Citación
Bruni, Sofia; Mercogliano, María Florencia; Mauro, Florencia Luciana; Cordo Russo, Rosalia Ines; Schillaci, Roxana; Cancer immune exclusion: breaking the barricade for a successful immunotherapy; Frontiers Media; Frontiers in Oncology; 13; 3-2023; 1-25
Compartir
Altmétricas